Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2005
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082402A1 Preventive/therapeutic agent for organ fibrosis
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2557809A1 Treatment of interstitial cystitis with vitamin d compounds
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050196408 Stimulating an immune response in a primate utilizing bacterial adhesin proteins and/or imunogenic fragments
09/07/2005EP1571155A1 Peptides and medicinal compositions containing the same
09/07/2005EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use
09/07/2005EP1569937A2 C-6 modified indazolylpyrrolotriazines
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
09/07/2005EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/07/2005EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/07/2005EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
09/07/2005EP1368062B1 Gel for the treatment of cats and dogs
09/07/2005CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665817A Process for preparing certain pyrrolotriazine compounds
09/07/2005CN1665811A Carbamate-substituted pyrazolopyridines
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665798A Refreshment capable of stimulating movement of digestive tract
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives
09/07/2005CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine
09/07/2005CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine
09/07/2005CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents
09/07/2005CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
09/07/2005CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
09/07/2005CN1665508A Use of pyrazolo[4, 3-d]pyrimidines
09/07/2005CN1665499A Drug composition for prevention or inhibition of advance of diabetic complication
09/07/2005CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage
09/07/2005CN1217926C Novel vitamin D analogues
09/07/2005CN1217657C Method of improving survival of patients
09/07/2005CN1217655C Fibrauretine slow releasing preparation
09/06/2005US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties
09/06/2005US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
09/06/2005US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/06/2005US6939568 Hydrated dressing containing metal microbiocide
09/06/2005CA2250395C Eprosartan dihydrate and a process for its production and formulation
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005079164A2 5α-REDUCTASE INHIBITORS
09/01/2005WO2005018627A8 Alpha-aminoamide derivatives useful as anti-inflammatory agents
09/01/2005WO2004072282A9 Nephropathy-associated gene
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192235 Compositions and methods for treating or preventing diseases of body passageways
09/01/2005US20050191713 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005DE102004003030A1 Composition containing a dihydroanthracene-disulfonic acid derivative, useful for treating inflammation of internal organs, e.g. ulcers, and cancer
09/01/2005CA2557539A1 Indanol derivative
08/2005
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568685A1 Aminoadamantane derivatives as therapeutic agents
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
08/31/2005EP1567526A1 Carbamic acid esters with an anticholinergic action
08/31/2005EP1567149A2 Pharmaceutical composition comprising beta-3-adrenoceptor agonists and antimuscarinic agents
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1434570B1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1330257B1 Gnrh analogues for treatment of urinary incontinence
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1066284B1 Benzo(c)quinolizine derivatives and their use as 5 alpha-reductases inhibitors
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0973819B1 Non-antigenic branched polymer conjugates
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005EP0721345B1 Prostatic cancer vaccine
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662661A Method for detecting increased susceptibility to tumours
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662527A Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 562